Subscribe to RSS
DOI: 10.1055/s-0029-1216891
Advances in Synthetic Approaches for the Preparation of Combretastatin-Based Anti-Cancer Agents
Publication History
Publication Date:
10 July 2009 (online)

Abstract
The natural product combretastatin A-4 (CA4) is a potent anti-cancer agent known for its antimitotic and antiangiogenic properties. The basic structure of CA4 has inspired the design and synthesis of a variety of medicinally active analogues that take advantage of the relatively simple stilbenoid architecture of the molecule. Here, we examine recent advances in the synthesis of various CA4-based analogues. A significant focus is placed on the modifications to the bridging alkene moiety of the stilbene scaffold for conformationally restricting the structure in a bioactive form. An effort is also made to discuss promising ring modifications and replacements, including the incorporation of indazole and oxindole rings, as well as the design and synthesis of amino-substituted analogues.
1 Introduction
2 New Approaches for the Synthesis of CA4
3 Synthetic Approaches for the Preparation of CA4 Analogues
3.1 Modification of the Bridging Moiety
3.2 Modification of the Bridging Moiety via Heterocyclic Functionalities
3.3 Macrocyclic Rings Affording Conformational Restriction to Combretastatin Analogues
4 Amine Substituents on Aryl Rings of Combretastatin Analogues
5 Conclusions
Key words
natural products - drugs - combretastatin - inhibitors - antitumor agents - medicinal chemistry
- 1a
Watt JM.Breyer-Brandwijk MG. In The Medicinal and Poisonous Plants of Southern and Eastern Africa 2nd ed.: E. and S. Livingstone; London: 1962.Reference Ris Wihthout Link - 1b
Gurib FA.Brendler T. In Medicinal and Aromatic Plants of Indian Ocean Islands: Madagascar, Comoros, Seychelles and Mascarenes Medpharm Scientific Publishers; Stuttgart: 2004.Reference Ris Wihthout Link - 2
Pettit GR.Cragg GM.Herald DL.Schmidt JM.Lobovanijaya P. Can. J. Chem. 1982, 60: 1374 - 3
Pinney KG.Jelinek C.Edvardsen K.Chaplin DJ.Pettit GR. In Anticancer Agents from Natural ProductsCragg GM.Kingston DGI.Newman DJ. CRC/Taylor and Francis; Boca Raton: 2005. p.23Reference Ris Wihthout Link - 4a
Cushman M.Nagarathnam D.Gopal D.Chakraborty AK.Lin CM.Hamel E. J. Med. Chem. 1991, 34: 2579Reference Ris Wihthout Link - 4b
Sackett DL. Pharm. Ther. 1993, 59: 163Reference Ris Wihthout Link - 4c
Hamel E. Med. Res. Rev. 1996, 16: 207Reference Ris Wihthout Link - 4d
Cirla A.Mann J. Nat. Prod. Rep. 2003, 20: 558Reference Ris Wihthout Link - 4e
Thorpe PE. Clin. Cancer Res. 2004, 10: 415Reference Ris Wihthout Link - 4f
Li Q.Sham HL. Exp. Opin. Ther. Pat. 2002, 12: 1663Reference Ris Wihthout Link - 4g
Nam NH. Curr. Med. Chem. 2003, 10: 1697Reference Ris Wihthout Link - 4h
Pettit GR.Lippert JW.Herald DL.Hamel E.Pettit RK. J. Nat. Prod. 2000, 63: 969Reference Ris Wihthout Link - 4i
Ohsumi K.Nakagawa R.Fukuda Y.Hatanaka T.Morinaga Y.Nihei Y.Ohishi K.Suga Y.Akiyama Y.Tsuji T. J. Med. Chem. 1998, 41: 3022Reference Ris Wihthout Link - 4j
Tron GC.Pirali T.Sorba G.Pagliai F.Busacca S.Genazzani AA. J. Med. Chem. 2006, 49: 3033Reference Ris Wihthout Link - 5
Lin CM.Singh SB.Chu PS.Dempcy RO.Schmidt JM.Pettit GR.Hamel E. Mol. Pharmacol. 1988, 34: 200 - 6a
Grosios K.Holwell SE.McGown AT.Pettit GR.Bibby MC. Br. J. Cancer 1999, 81: 1318Reference Ris Wihthout Link - 6b
Horsman MR.Murata R.Breidahl T.Nielsen FU.Maxwell RJ.Stodkiled-Jorgensen H.Overgaard J. Adv. Exp. Med. Biol. 2000, 476: 311Reference Ris Wihthout Link - 6c
Siemann DW.Mercer E.Lepler S.Rojiani AM. Int. J. Cancer 2002, 99: 1Reference Ris Wihthout Link - 6d
Galbraith SM.Maxwell RJ.Lodge MA.Tozer GM.Wilson J.Taylor NJ.Stirling JJ.Sena L.Padhani AR.Rustin GJ. J. Clin. Oncol. 2003, 21: 2831Reference Ris Wihthout Link - For antivascular activity of CA4 at low concentrations, see:
- 6e
Tozer GM.Kanthou C.Parkins CS.Hill SA. Int. J. Exp. Pathol. 2002, 83: 21Reference Ris Wihthout Link - For examples of vascular-targeting tubulin binding compounds in prodrug form, see:
- 6f
Hadimani MB.Kessler RJ.Kautz JA.Ghatak A.Shirali AR.O’Dell H.Garner CM.Pinney KG. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2002, 58: 330Reference Ris Wihthout Link - 6g
Siemann DW.Rojiani AM. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54: 1512Reference Ris Wihthout Link - 6h
Chaplin DJ.Hill SA. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54: 1491Reference Ris Wihthout Link - 6i
Thorpe PE.Chaplin DJ.Blakeley DC. Cancer Res. 2003, 63: 1144Reference Ris Wihthout Link - For a review on the current status of CA4P, see:
- 6j
Siemann DW.Chaplin DJ.Walicke PA. Expert Opin. Investig. Drugs 2009, 18: 189Reference Ris Wihthout Link - 7a
Rustin GJS.Galbraith SM.Anderson H.Stratford M.Folkes LK.Sena L.Gumbrell L.Price PM. J. Clin. Oncol. 2003, 21: 2815Reference Ris Wihthout Link - 7b
Dowlati A.Robertson K.Cooney M.Petros WP.Stratford M.Jesberger J.Rafie N.Overmoyer B.Makkar V.Stambler B.Taylor A.Waas J.Lewin JS.McCrae KR.Remick SC. Cancer Res. 2002, 62: 3408Reference Ris Wihthout Link - 8
Lee JC.Harrison D.Timasheff SN. J. Biol. Chem. 1975, 24: 9276 - 9
Dustin P. Microtubules 2nd ed.: Springer-Verlag; Berlin: 1984.Reference Ris Wihthout Link - 10
Jordan MA.Wilson L. Nat. Rev. Cancer 2004, 4: 253 - 11a
Hamel E. Pharm. Ther. 1992, 55: 31Reference Ris Wihthout Link - 11b
Shih C.Teicher BA. Curr. Pharm. Des. 2001, 7: 1259Reference Ris Wihthout Link - 11c
Gupta S.Bhattacharya B. Mol. Cell. Biochem. 2003, 253: 41Reference Ris Wihthout Link - 12
Atalay C.Deliloglu GI.Irkkan C.Gunduz U. Tumour Biol. 2006, 27: 309 - 13
Chaudhary A.Pandeya SN.Kumar P.Sharma PP.Gupta S.Soni N.Verma KK.Bhardwaj G. Mini Rev. Med. Chem. 2007, 7: 1186 ; and references therein - For the synthesis of (-)-combretastatin, see:
- 14a
Pettit GR.Singh SB.Cragg GM. J. Org. Chem. 1985, 50: 3404Reference Ris Wihthout Link - For the synthesis of combretastatin-A1 and combretastatin-B1, see:
- 14b
Pettit GR.Singh SB.Niven ML.Hamel E.Schmidt JM. J. Nat. Prod. 1987, 50: 119Reference Ris Wihthout Link - For the synthesis of combretastatin-A2, combretastatin-A3 and combretastatin-B2, see:
- 14c
Pettit GR.Singh SB. Can. J. Chem. 1987, 65: 2390Reference Ris Wihthout Link - For a previous report on the synthesis of (±)-combretastatin, see:
- 14d
Annapurna GS.Deshpande VH. Synth. Commun. 1983, 13: 1075Reference Ris Wihthout Link - 15
Pettit GR.Singh SB.Boyd MR.Hamel E.Pettit RK.Schmidt JM.Hogan F. J. Med. Chem. 1995, 38: 1666 - 16
Harrowven DC.Guy IL.Howell M.Packam G. Synlett 2006, 2977 - 17a
Dunne EC.Coyne J.Crowley PB.Gilheany DG. Tetrahedron Lett. 2002, 43: 2449Reference Ris Wihthout Link - 17b See also:
Hwang J.-J.Lin R.-L.Shieh R.-L.Jwo J.-J. J. Mol. Catal. A: Chem. 1999, 142: 125Reference Ris Wihthout Link - 17c
Sinhababu AK.Borchardt RT. J. Org. Chem. 1983, 48: 2356Reference Ris Wihthout Link - 18
Robinson JE.Taylor RJK. Chem. Commun. 2007, 1617 - 19
Chan T.-L.Fong S.Li Y.Man T.-O.Poon C.-D. J. Chem. Soc., Chem. Commun. 1994, 1771 - 20
Yang G.Franck RW.Byun H.-S.Bittman R.Samadder P.Arthur G. Org. Lett. 1999, 1: 2149 - 21
Meyers CY.Malte AM.Matthews WS. J. Am. Chem. Soc. 1969, 91: 7510 - 22
Giraud A.Provot O.Hamze A.Brion J.-D.Alami M. Tetrahedron Lett. 2008, 49: 1107 - 23a
Hamze A.Provot O.Brion J.-D.Alami M. Synthesis 2007, 2025Reference Ris Wihthout Link - 23b
Hamze A.Provot O.Alami M.Brion J.-D. Org. Lett. 2005, 7: 5625Reference Ris Wihthout Link - 24a
Lindlar H. Helv. Chim. Acta 1952, 35: 446Reference Ris Wihthout Link - 24b
Lindlar H.Dubuis R. Org. Synth. 1973, 5: 880Reference Ris Wihthout Link - 25a
Bujard M.Ferri F.Alami M. Tetrahedron Lett. 1998, 39: 4243Reference Ris Wihthout Link - 25b
Liron F.Le Garrec P.Alami M. Synlett 1999, 246Reference Ris Wihthout Link - 25c
Alami M.Liron F.Gervais M.Peyrat J.-F.Brion J.-D. Angew. Chem. Int. Ed. 2002, 41: 1578Reference Ris Wihthout Link - 25d
Liron F.Gervais M.Peyrat J.-F.Alami M.Brion J.-D. Tetrahedron Lett. 2003, 44: 2789Reference Ris Wihthout Link - 25e
Hamze A.Provot O.Brion J.-D.Alami M. J. Org. Chem. 2007, 72: 3868Reference Ris Wihthout Link - 26
Zou Y.Xiao C.-F.Zhong R.-Q.Wei W.Huang W.-M.He S.-J. J. Chem. Res. 2008, 354 - 27
Camacho-Davila AA. Synth. Commun. 2008, 3823 - 28
Pettit GR.Cragg GM.Singh SB. J. Nat. Prod. 1987, 56: 386 - 29
Ravelli RBG.Gigant B.Curmi PA.Jourdain I.Lachkar S.Sobel A.Knossow M. Nature 2004, 428: 198 - For examples of bridge modified tubulin polymerization inhibitors, see:
- 30a Synthesis of phenstatin:
Pettit GR.Toki B.Herald DL.Verdier-Pinard P.Boyd MR.Hamel E.Pettit RK. J. Med. Chem. 1998, 41: 1688Reference Ris Wihthout Link - 30b Synthesis of hydroxy-phenstatin:
Pettit GR.Grealish MP.Herald DL.Boyd MR.Hamel E.Pettit RK. J. Med. Chem. 2000, 43: 2731Reference Ris Wihthout Link - 31
Gurjar MK.Wakharkar RD.Singh AT.Jaggi M.Borate HB.Shinde PD.Verma R.Rajendran P.Dutt S.Singh G.Sanna VK.Singh MK.Srivastava SK.Mahajan VA.Jadhav VH.Dutta K.Krishnan K.Chaudhary A.Agarwal SK.Mukherjee R.Burman AC. J. Med. Chem. 2007, 50: 1744 - 32
Gurjar MK,Wakharkar RD,Desiraju GR,Nangia A,Yadav JS,Burman AC,Mukherjee R,Borate HB,Chandrasekhar S,Jaggi M,Singh AT,Kapoor KK,Sarkhel S, andSairam KVVM. inventors; US Pat. Appl. Publ. US 2003229146.Reference Ris Wihthout Link - 33
Trost BM.Pinkerton AB. J. Org. Chem. 2001, 66: 7714 - 34
Kerr DJ.Hamel E.Jung MK.Flynn BL. Bioorg. Med. Chem. 2007, 15: 3290 - 35
Kerr DJ.Metje C.Flynn BL. Chem. Commun. 2003, 1380 - 36
Sriram M.Hall JJ.Grohman NC.Strecker TE.Wooton T.Franken A.Trawick ML.Pinney KG. Bioorg. Med. Chem. 2008, 16: 8161 - 37
Hu L.Li Z.-R.Li Y.Qu J.Ling Y.-H.Jiang J.-D.Boykin DW. J. Med. Chem. 2006, 49: 6273 - 38
Mitsumori S.Tsuri T.Honma T.Hiramatsu Y.Okada T.Hashizume H.Inagaki M.Arimura A.Yasui K.Asanuma F.Kishino J.Ohtani M. J. Med. Chem. 2003, 46: 2436 - 39
Mousset C.Giraud A.Provot O.Hamze A.Bignon J.Liu J.-M.Thoret S.Dubois J.Brion J.-D.Alami M. Bioorg. Med. Chem. Lett. 2008, 18: 3266 - 40
Giraud A.Provot O.Peyrat J.-F.Alami M.Brion J.-D. Tetrahedron 2006, 62: 7667 - 41
Sun L.Vasilevich NI.Fuselier JA.Hocart SJ.Coy DH. Bioorg. Med. Chem. Lett. 2004, 14: 2041 - 42
Kaffy J.Monneret C.Mailliet P.Commercon A.Pontinkis R. Tetrahedron Lett. 2004, 45: 3359 - 43
Wang L.Woods KW.Li Q.Barr KJ.McCroskey RW.Hannick SM.Gherke L.Credo RB.Hui Y.-H.Marsh K.Warner RJ.Lee Y.Zielenski-Mozng N.Frost D.Rosenberg S.-H.Sham HL. J. Med. Chem. 2002, 45: 1697 - 44
LeBlanc R.Dickson J.Brown T.Stewart M.Pati H.VanDerveer D.Arman H.Harris J.Pennington W.Holt H.Lee M. Bioorg. Med. Chem. 2005, 13: 6025 - 45
Flynn BL.Flynn GP.Hamel E.Jung MK. Bioorg. Med. Chem. Lett. 2001, 11: 2341 - 46
Pinney KG.Bounds AD.Dingeman KM.Mocharla VP.Pettit GR.Bai R.Hamel E. Bioorg. Med. Chem. Lett. 1999, 9: 1081 - 47
Kim Y.Nam N.-H.You Y.-J.Ahn B.-Z. Bioorg. Med. Chem. Lett. 2002, 12: 719 - 48
Zhang Q.Peng Y.Wang XI.Keenan SM.Arora S.Welsh WJ. J. Med. Chem. 2007, 50: 749 - 49
Curphey TJ. J. Org. Chem. 2002, 67: 6467 - 51
Nguyen TL.McGrath C.Hermone AR.Burnett JC.Zaharevitz DW.Day BW.Wipf P.Hamel E.Gussio RA. J. Med. Chem. 2005, 48: 6107 - 52
Odlo K.Hentzen J.Chabert JFD.Ducki S.Gani OABSM.Sylte I.Skrede M.Florenes VA.Hansen TV. Bioorg. Med. Chem. 2008, 16: 4829 - 53
Colvin EW.Hamill BJ. J. Chem. Soc., Chem. Commun. 1973, 151 - 54
Huisgen R.Szeimies G.Mobius L. Chem. Ber. 1967, 100: 2494 - 55
Johnson M.Younglove B.Lee L.LeBlanc R.Holt H.Hills P.Mackay H.Brown T.Mooberry SL.Lee M. Bioorg. Med. Chem. Lett. 2007, 17: 5897 - 56
Ducki S.Forrest R.Hadfield JH.Kendall A.Lawrence NJ.McGown AT.Rennison D. Bioorg. Med. Chem. Lett. 1998, 8: 1051 - 57a
Sun L.Tran N.Tang F.App H.Hirth P.McMahon G.Tang C. J. Med. Chem. 1998, 41: 2588Reference Ris Wihthout Link - 57b
Sun L.Tran N.Liang C.Tang F.Rice A.Schreck R.Waltz K.Shawver LK.McMahon G.Tang C. J. Med. Chem. 1999, 42: 5120Reference Ris Wihthout Link - 58
Pandit B.Sun Y.Chen P.Sackett DL.Hu Z.Rich W.Li C.Lewis A.Schaefer K.Li P.-K. Bioorg. Med. Chem. 2006, 14: 6492 - 59
Li P.-K.Xiao Z.Hu Z.Pandit B.Sun Y.Sackett DL.Werbovetz K.Lewis A.Johnsamuel J. Bioorg. Med. Chem. Lett. 2005, 15: 5382 - 60
Quallich G.Morrissey P. Synthesis 1993, 51 - 61
Arthuis M.Pontikis R.Florent J.-C. Tetrahedron Lett. 2007, 48: 6397 - 62
Kaffy J.Pontikis R.Florent J.-C.Monneret C. Org. Biomol. Chem. 2005, 5: 2657 - 63a
Cheung WS.Patch RJ.Player MR. J. Org. Chem. 2005, 70: 3741Reference Ris Wihthout Link - 63b
Yanada R.Obika S.Inokuma T.Yanada K.Yamashita M.Ohta S.Takemoto Y. J. Org. Chem. 2005, 70: 6972Reference Ris Wihthout Link - 64
Couty S.Liégault B.Meyer C.Cossy J. Org. Lett. 2004, 6: 2511 - 65a
Oh CH.Lim YM. Tetrahedron Lett. 2003, 44: 267Reference Ris Wihthout Link - 65b
Min S.-H.Pang S.-J.Cho C.-G. Tetrahedron Lett. 2003, 44: 4439Reference Ris Wihthout Link - 66
Burns B.Grigg R.Sridharan V.Stevenson P.Sukirthalingam S.Worakun T. Tetrahedron Lett. 1989, 30: 1135 - 67
Yanada R.Obika S.Kobayashi Y.Inokuma T.Oyama M.Yanada K.Takemoto Y. Adv. Synth. Catal. 2005, 347: 1632 - 68
Brunton SA.Jones K. J. Chem. Soc., Perkin Trans. 1 2000, 763 - 69
Duan J.-X.Cai X.Meng F.Lan L.Hart C.Matteucci M. J. Med. Chem. 2007, 50: 1001 - 70
Provot O.Giraud A.Peyrat J.Alami M.Brion J. Tetrahedron Lett. 2005, 49: 8547 - 71
Idiya GF.Nataliya AZ. Tetrahedron Lett. 2005, 29: 5453 - 72
Wu M.Sun Q.Yang C.Chen D.Ding J.Chen Y.Lin L.Xie Y. Bioorg. Med. Chem. Lett. 2007, 17: 869 - 73
Napolitano E.Ramacciotti A. Gazz. Chim. Ital. 1989, 119: 19 - 74
Tong YG.Zhang XW.Geng MY.Yue JM.Xin XL.Fang T.Xu S.Tong LJ.Li MH.Zhang C.Li WH.Lin LP.Ding J. Mol. Pharmacol. 2006, 69: 1226 - 75
Lee L.Davis R.Vanderham J.Hills P.Mackay H.Brown T.Mooberry SL.Lee M. Eur. J. Med. Chem. 2008, 43: 2011 - 76 For the synthesis and a limited
cytotoxicity study of chalcones, see:
Dickson J.Flores L.Stewart M.Holt HL.LeBlanc R.Lee M. J. Chem. Educ. 2006, 83: 934 - 77
Rappl C.Barbier P.Bourgarel-Rey V.Gregoire C.Gilli R.Carre M.Combes S.Finet J.-P.Peyrot V. Biochemistry 2006, 45: 9210 - 78
Bailly C.Bal C.Barbier P.Combes S.Finet J.-P.Hildebrand M.-P.Peyrot V.Wattez N. J. Med. Chem. 2003, 46: 5437 - 79
Combes S.Finet J.-P.Siri D. J. Chem. Soc., Perkin Trans. 1 2002, 38 - 80a
Ishiyama T.Abe S.Miyaura N.Suzuki A. Chem. Lett. 1992, 691Reference Ris Wihthout Link - 80b
Miyaura N.Ishiyama T.Sasaki H.Ishikawa M.Satoh M.Suzuki A. J. Am. Chem. Soc. 1989, 111: 314Reference Ris Wihthout Link - 80c
Miyaura N.Yanagi T.Suzuki A. Synth. Commun. 1981, 11: 513Reference Ris Wihthout Link - 80d
Miyaura N.Yamada K.Suzuki A. Tetrahedron Lett. 1979, 36: 3437Reference Ris Wihthout Link - 80e
Miyaura N.Suzuki A. Chem. Rev. 1995, 95: 2457Reference Ris Wihthout Link - 80f
Miyaura N. Top. Curr. Chem. 2002, 219: 11Reference Ris Wihthout Link - 80g
Suzuki A. J. Organomet. Chem. 1999, 576: 147Reference Ris Wihthout Link - 80h
Hassan J.Sevignon M.Gozzi C.Schulz E.Lemaire M. Chem. Rev. 2002, 102: 1359Reference Ris Wihthout Link - 81a
Walker SD.Barder TE.Martinelli JR.Buchwald SL. Angew. Chem. Int. Ed. 2004, 43: 1871Reference Ris Wihthout Link - 81b
Zhou J.Fu GC. J. Am. Chem. Soc. 2004, 126: 1340Reference Ris Wihthout Link - 81c
Brenstrum T.Gerristma DA.Adjabeng GM.Frampton CS.Britten J.Rabertson AJ.McNulty J.Capretta A. J. Org. Chem. 2004, 69: 7635Reference Ris Wihthout Link - 81d
Arensten K.Caddick S.Cloke FGN.Herring AP.Hitchcock PB. Tetrahedron Lett. 2004, 45: 3511Reference Ris Wihthout Link - 81e
Gstottmayr CWK.Bohm VPW.Herdtweck E.Grosche M.Herrmann WA. Angew. Chem. Int. Ed. 2002, 41: 1363Reference Ris Wihthout Link - 81f
Navarro O.Kaur H.Poppet B.Mahjoor P.Nolan SP. J. Org. Chem. 2004, 69: 3173Reference Ris Wihthout Link - 81g
Singh R.Viciu MS.Kramareva N.Navarro O.Nolan SP. Org. Lett. 2005, 7: 1829Reference Ris Wihthout Link - 82a
Boland GM.Donnelly DMX.Finet J.-P.Rea MD. J. Chem. Soc., Perkin Trans. 1 1996, 2591Reference Ris Wihthout Link - 82b
Donnelly DMX.Finet J.-P.Guiry PJ.Rea MD. Synth. Commun. 1999, 29: 2719Reference Ris Wihthout Link - 83
Ganina OG.Daras E.Bourgarel-Rey V.Peyrot V.Andresyuk AN.Finet J.-P.Federov AY.Beletskaya I.Combes S. Bioorg. Med. Chem. 2008, 16: 8806 - 84a
Pettit GR.Singh SB.Niven ML. J. Am. Chem. Soc. 1988, 110: 8539Reference Ris Wihthout Link - 84b
Singh SB.Pettit GR. J. Org. Chem. 1990, 55: 2797Reference Ris Wihthout Link - 85
Mateo C.Lopez V.Medarde M.Pelaez R. Chem. Eur. J. 2007, 13: 7246 - 86
Maya ABS.Pérez-Melero C.Mateo C.Alonso D.Fernández JL.Gajate C.Mollinedo F.Peláez R.Caballero E.Medarde M. J. Med. Chem. 2005, 48: 556 - 87a
Mitsunobu O. Synthesis 1981, 1Reference Ris Wihthout Link - 87b
Hughes DL. Org. React. 1992, 42: 335Reference Ris Wihthout Link - 87c
Hughes DL. Org. Prep. Proced. Int. 1996, 28: 127Reference Ris Wihthout Link - 88
McMurry JE. Chem. Rev. 1989, 89: 1513 - 89
Mateo C.Pérez-Melero C.Peláez R.Medarde M. J. Org. Chem. 2005, 70: 6544 - 90
Mateo C.Alvarez R.Perez-Melero C.Pelaez R.Medarde M. Bioorg. Med. Chem. Lett. 2007, 17: 6316 - 91
Pettit GR.Rhodes MR.Herald DL.Hamel E.Schmidt JM.Pettit RK. J. Med. Chem. 2005, 48: 4087 - 92a
Monk KA.Siles R.Hadimani MB.Mugabe BE.Ackley JF.Studerus SW.Edvardsen K.Trawick ML.Garner CM.Rhodes MR.Pettit GR.Pinney KG. Bioorg. Med. Chem. 2006, 14: 3231Reference Ris Wihthout Link - For earlier reports on the synthesis of 3′-amino combretastatin tubulin polymerization inhibitors, see:
- 92b
Ref. 4i.
Reference Ris Wihthout Link - 92c
Pinney KG.Mejia MP.Villalobos VM.Rosenquist BE.Pettit GR.Verdier-Pinard P.Hamel E. Bioorg. Med. Chem. 2000, 8: 2417Reference Ris Wihthout Link - 93
Chang J.-Y.Yang M.-F.Chang C.-Y.Chn C.-M.Kuo C.-C.Liou J.-P. J. Med. Chem. 1996, 49: 6412 - 94
Siles R.Ackley JF.Hadimani MB.Hall JJ.Mugabe BE.Guddneppanavar R.Monk KA.Chapuis J.-C.Pettit GR.Chaplin DJ.Edvardsen K.Trawick ML.Garner CM.Pinney KG. J. Nat. Prod. 2008, 71: 313 - 95
Gal’bershtam MA.Budarina ZN. Zh. Org. Khim. 1969, 5: 953 - 96
Simonsen JL.Rau MG. J. Chem. Soc., Dalton Trans. 1917, 220: 236 - 97
Monk K.Siles R.Pinney KG.Garner CM. Tetrahedron Lett. 2003, 44: 3759 - 98
Chaplin DJ,Garner CM,Kane RR,Pinney KG,Prezioso JA, andEdvardsen K. inventors; United States Patent US 6919324B2.Reference Ris Wihthout Link
References
The conformation from the X-ray crystal structure was utilized in molecular dynamics simulations by docking it into the colchicines binding site of tubulin by Zhang et al.48